FOLH1 and non-small cell lung carcinoma: The percentage of SCLC patients with PSMA-positive NECs did not significantly differ from that of NSCLC patients and did not show significant correlation with age at diagnosis, gender, or clinical stage (limited and extensive stages) (data not shown).